Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn’s Disease
Open Access
- 17 September 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Abstract
Non-responsiveness to anti-TNF-α therapies presents relevant rates in inflammatory bowel disease patients, presenting the need to find biomarkers involved in therapeutic efficacy. Herein, we demonstrate that higher levels of colonic formyl peptide receptor 1 and annexin A1 correlate with histological recovery in Crohn’s disease patients under remission. Using the dextran sulfate sodium colitis model in mice, we suggest that infliximab induces annexin A1 expression and secretion in activated intestinal leukocytes. Conversely, this mechanism might stimulate epithelial formyl peptide receptors, inducing wound healing and consequent histological remission. Our data indicate that assessing intestinal expressions of formyl peptide receptors and annexin A1 might provide precious information on the disease activity and responsiveness to infliximab in inflammatory bowel disease patients.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundação de Amparo à Pesquisa do Estado de São Paulo
This publication has 41 references indexed in Scilit:
- Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns DiseasePLOS ONE, 2013
- Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repairJournal of Clinical Investigation, 2012
- Up-Regulation of Annexin-A1 and Lipoxin A4 in Individuals with Ulcerative Colitis May Promote Mucosal HomeostasisPLOS ONE, 2012
- Enteric Commensal Bacteria Induce Extracellular Signal-regulated Kinase Pathway Signaling via Formyl Peptide Receptor-dependent Redox Modulation of Dual Specific Phosphatase 3Journal of Biological Chemistry, 2011
- Wound healing of intestinal epithelial cellsWorld Journal of Gastroenterology, 2011
- Commensal-Epithelial Signaling Mediated via Formyl Peptide ReceptorsThe American Journal of Pathology, 2010
- Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha TherapiesBioDrugs, 2010
- Annexin‐1 signals mitogen‐stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2The FASEB Journal, 2010
- Clinical Pharmacokinetics and Use??of??InfliximabClinical Pharmacokinetics, 2007
- Formyl peptide receptors: A promiscuous subfamily of G protein-coupled receptors controlling immune responsesCytokine & Growth Factor Reviews, 2006